{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,3]],"date-time":"2026-07-03T16:09:20Z","timestamp":1783094960330,"version":"3.54.6"},"reference-count":18,"publisher":"MDPI AG","issue":"6","license":[{"start":{"date-parts":[[2023,3,8]],"date-time":"2023-03-08T00:00:00Z","timestamp":1678233600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Cancers"],"abstract":"<jats:p>Background: There has been no comparison of the prognoses of Korean patients who underwent curative surgery for cancer located at the cardia or subcardia of the stomach. We performed this comparison and further investigated the prognostic significance of esophagogastric junction (EGJ) invasion in patients. Methods: The medical records of patients (n = 511) who were diagnosed with cardia or subcardia cancer and underwent surgery between January 2010 and May 2019 were retrospectively reviewed. Patients were further categorized into four groups for analysis: subcardia gastric cancer (sGC; subcardia cancer without EGJ invasion; n = 97), AEG (adenocarcinoma of the esophagogastric junction) type III (subcardia cancer with EGJ invasion, n = 54), AEG type II without EGJ invasion (n = 158), and AEG type II with EGJ invasion (n = 202). We compared the overall survival of the four groups using a gastric cancer staging system and evaluated the prognostic significance of EGJ invasion with multivariate analysis. Results: The median follow-up of patients was 46.0 months (range: 0\u2013124 months). There was significant difference in overall survival curves among the four groups (p &lt; 0.001). Subgroup analysis showed a significant difference in overall survival between the groups with and without EGJ invasion (p &lt; 0.001). Cancers with EGJ invasion were more frequently in the cardia (p &lt; 0.001), had a larger size (p &lt; 0.001), and showed a more advanced pathologic stage (stages II and III; 67.6% versus 33.7%, p &lt; 0.001) than those without EGJ invasion. EGJ invasion and the pathologic stage were significant independent prognostic factors of overall survival in cardia and subcardia cancer patients (hazard ratio 2.24, 95% confidence interval 1.32\u20133.81, p = 0.003). Conclusion: The overall survival between patients with cardia or subcardia cancer was significantly different according to EGJ invasion. EGJ invasion was an independent prognostic factor and should be considered for staging. Additional research is needed to apply this feature to gastric and esophageal cancer classification.<\/jats:p>","DOI":"10.3390\/cancers15061656","type":"journal-article","created":{"date-parts":[[2023,3,8]],"date-time":"2023-03-08T02:30:23Z","timestamp":1678242623000},"page":"1656","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["Prognostic Significance of Esophagogastric Junction Invasion in Patients with Adenocarcinoma of the Cardia or Subcardia"],"prefix":"10.3390","volume":"15","author":[{"given":"Sung Eun","family":"Oh","sequence":"first","affiliation":[{"name":"Department of Surgery, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul 06351, Republic of Korea"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sujin","family":"Park","sequence":"additional","affiliation":[{"name":"Department of Pathology, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul 06351, Republic of Korea"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Soomin","family":"Ahn","sequence":"additional","affiliation":[{"name":"Department of Pathology, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul 06351, Republic of Korea"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ji Yeong","family":"An","sequence":"additional","affiliation":[{"name":"Department of Surgery, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul 06351, Republic of Korea"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jun Ho","family":"Lee","sequence":"additional","affiliation":[{"name":"Department of Surgery, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul 06351, Republic of Korea"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tae Sung","family":"Sohn","sequence":"additional","affiliation":[{"name":"Department of Surgery, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul 06351, Republic of Korea"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jae Moon","family":"Bae","sequence":"additional","affiliation":[{"name":"Department of Surgery, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul 06351, Republic of Korea"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Min-Gew","family":"Choi","sequence":"additional","affiliation":[{"name":"Department of Surgery, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul 06351, Republic of Korea"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2023,3,8]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/j.semradonc.2012.09.008","article-title":"Epidemiology and risk factors for gastroesophageal junction tumors: Understanding the rising incidence of this disease","volume":"23","author":"Buas","year":"2013","journal-title":"Semin. Radiat. Oncol."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"139","DOI":"10.5230\/jgc.2019.19.e18","article-title":"History of Esophagogastric Junction Cancer Treatment and Current Surgical Management in Western Countries","volume":"19","author":"Berlth","year":"2019","journal-title":"J. Gastric Cancer"},{"key":"ref_3","doi-asserted-by":"crossref","unstructured":"Information Committee of the Korean Gastric Cancer Association (2021). Korean Gastric Cancer Association-Led Nationwide Survey on Surgically Treated Gastric Cancers in 2019. J. Gastric Cancer, 21, 221\u2013235.","DOI":"10.5230\/jgc.2021.21.e27"},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1159\/000519602","article-title":"Epidemiological Review of Gastroesophageal Junction Adenocarcinoma in Asian Countries","volume":"103","author":"Manabe","year":"2022","journal-title":"Digestion"},{"key":"ref_5","first-page":"173","article-title":"CARCINOMA OF THE CARDIA: Carcinoma of the gastroesophageal junction-classification, pathology, and extent of resection","volume":"9","author":"Siewert","year":"1996","journal-title":"Dis. Esophagus"},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"1721","DOI":"10.1245\/s10434-010-1024-1","article-title":"7th edition of the AJCC Cancer Staging Manual: Esophagus and esophagogastric junction","volume":"17","author":"Rice","year":"2010","journal-title":"Ann. Surg. Oncol."},{"key":"ref_7","unstructured":"Amin, M.B., Edge, S., Greene, F., Byrd, D.R., Brookland, R.K., Washington, M.K., Gershenwald, J.E., Compton, C.C., Hess, K.R., and Sullivan, D.C. (2017). AJCC Cancer Staging Manual, Springer International Publishing. [8th ed.]."},{"key":"ref_8","doi-asserted-by":"crossref","unstructured":"Guideline Committee of the Korean Gastric Cancer Association, and Development Working Group & Review Panel (2019). Korean Practice Guideline for Gastric Cancer 2018: An Evidence-based, Multi-disciplinary Approach. J. Gastric Cancer, 19, 1\u201348.","DOI":"10.5230\/jgc.2019.19.e8"},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"209","DOI":"10.5230\/jgc.2018.18.e28","article-title":"Surgical Treatment of Gastroesophageal Junction Cancer","volume":"18","author":"Hashimoto","year":"2018","journal-title":"J. Gastric Cancer"},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"506","DOI":"10.1007\/s10120-018-0890-2","article-title":"Comparison between gastric and esophageal classification system among adenocarcinomas of esophagogastric junction according to AJCC 8th edition: A retrospective observational study from two high-volume institutions in China","volume":"22","author":"Liu","year":"2019","journal-title":"Gastric Cancer"},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"1512","DOI":"10.1097\/PAS.0b013e3182294764","article-title":"How to classify adenocarcinomas of the esophagogastric junction: As esophageal or gastric cancer?","volume":"35","author":"Gertler","year":"2011","journal-title":"Am. J. Surg. Pathol."},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"908","DOI":"10.1097\/SLA.0b013e31824beb95","article-title":"Should adenocarcinoma of the esophagogastric junction be classified as esophageal cancer? A comparative analysis according to the seventh AJCC TNM classification","volume":"255","author":"Suh","year":"2012","journal-title":"Ann. Surg."},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"773","DOI":"10.1245\/s10434-012-2780-x","article-title":"Esophagus or Stomach? The Seventh TNM Classification for Siewert Type II\/III Junctional Adenocarcinoma","volume":"20","author":"Hasegawa","year":"2013","journal-title":"Ann. Surg. Oncol."},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"856","DOI":"10.1002\/jso.23152","article-title":"Impact of esophageal invasion on clinicopathological characteristics and long-term outcome of adenocarcinoma of the subcardia","volume":"106","author":"Tokunaga","year":"2012","journal-title":"J. Surg. Oncol."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"1028","DOI":"10.1111\/j.1572-0241.1998.00362.x","article-title":"Practice guidelines on the diagnosis, surveillance, and therapy of Barrett\u2019s esophagus. The Practice Parameters Committee of the American College of Gastroenterology","volume":"93","author":"Sampliner","year":"1998","journal-title":"Am. J. Gastroenterol."},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1007\/s10388-006-0089-1","article-title":"Histopathological features of the esophagogastric junction","volume":"3","author":"Nakanishi","year":"2006","journal-title":"Esophagus"},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1007\/BF00294713","article-title":"Problem of proximal third gastric carcinoma","volume":"19","author":"Siewert","year":"1995","journal-title":"World J. Surg."},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"520","DOI":"10.1007\/s10434-000-0520-0","article-title":"Proximal versus distal gastric carcinoma\u2014What are the differences?","volume":"7","author":"Piso","year":"2000","journal-title":"Ann. Surg. Oncol."}],"container-title":["Cancers"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2072-6694\/15\/6\/1656\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,10]],"date-time":"2025-10-10T18:50:40Z","timestamp":1760122240000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2072-6694\/15\/6\/1656"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,3,8]]},"references-count":18,"journal-issue":{"issue":"6","published-online":{"date-parts":[[2023,3]]}},"alternative-id":["cancers15061656"],"URL":"https:\/\/doi.org\/10.3390\/cancers15061656","relation":{},"ISSN":["2072-6694"],"issn-type":[{"value":"2072-6694","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,3,8]]}}}